Michael Byrnes, VP, Finance & Treasurer at Ocera Therapeutics, Inc. (OCRX), bought 2,000 shares at $4.81 ($10K) on 2014-10-01, disclosed to the SEC on 2014-10-02.
Open-market purchase of $10k OCRX by VP, Finance & Treasurer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| OCRX | BUY | 2016-01-19 | $7K | — | Filing → |
| OCRX | BUY | 2015-05-06 | $9K | — | Filing → |